Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Wasserman

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 1, 1997
The incidence of breast cancer following mantle field radiation therapy as a function of dose and techniqueA Tinger, T H Wasserman, E E Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug scheduleC N Coleman, T H Wasserman, R C Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1987
Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology GroupJ R Simpson, M Bauer, T H Wasserman, et al.
International Urology and Nephrology|January 1, 1992
Positron emission tomography in the study of acute radiation effects on renal blood flow in dogsA Kuten, H D Roval, L K Griffeth, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostateB J Kobeissi, M Gupta, C A Perez, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 1999
Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology GroupP W Grigsby, K Winter, T H Wasserman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experienceD J Lee, T L Phillips, C N Coleman, et al.
Missouri Medicine|April 1, 1995
Stereotactic external beam irradiation using a linear accelerator: the Washington University experienceJ R Simpson, K M Rich, R E Drzymala, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
The Radiation Therapy Oncology Group: an outline of clinical research activitiesL Brady, S Kramer, T H Wasserman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Cost accounting in radiation oncology: a computer-based model for reimbursementC A Perez, B Kobeissi, B D Smith, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|March 1, 1997
The incidence of breast cancer following mantle field radiation therapy as a function of dose and techniqueA Tinger, T H Wasserman, E E Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug scheduleC N Coleman, T H Wasserman, R C Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1987
Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology GroupJ R Simpson, M Bauer, T H Wasserman, et al.
International Urology and Nephrology|January 1, 1992
Positron emission tomography in the study of acute radiation effects on renal blood flow in dogsA Kuten, H D Roval, L K Griffeth, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostateB J Kobeissi, M Gupta, C A Perez, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 1999
Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology GroupP W Grigsby, K Winter, T H Wasserman, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experienceD J Lee, T L Phillips, C N Coleman, et al.
Missouri Medicine|April 1, 1995
Stereotactic external beam irradiation using a linear accelerator: the Washington University experienceJ R Simpson, K M Rich, R E Drzymala, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
The Radiation Therapy Oncology Group: an outline of clinical research activitiesL Brady, S Kramer, T H Wasserman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Cost accounting in radiation oncology: a computer-based model for reimbursementC A Perez, B Kobeissi, B D Smith, et al.
Pageof 9